Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND: Fixed-extended-duration Antibiotics vs Standard Care in cIAI
NCT05148702Phase 3Active, not recruiting
- Start
- Oct 2022
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Intra-abdominal infection (IAI) (2 arms). Primary endpoint: Treatment failure at 180 days. Started Oct 2022; status: active, not recruiting.
02
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT05148702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148702.